Study S000001

Effects of GLP-1 Analogues on Fluid Intake in Healthy Volunteers - "The GATE-Study"

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03141632
Acronym: GATE
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: QUADRUPLE
Status: COMPLETED
Enrollment: 17
Start: 2016-10-17
Primary completion: 2017-05
Lead sponsor: University Hospital, Basel, Switzerland
Conditions: Thirst; Water-Electrolyte Imbalance
Interventions: DRUG:Dulaglutide; OTHER:Placebo
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Fluid intake [8 hours]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0006214	Effect of a 3-Week Treatment with GLP-1 Receptor Agonists on Vasoactive Hormones in Euvolemic Participants. Vukajlovic T, The Journal of clinical endocrinology and metabolism	2022	Randomized trial	PMID 35134170 DOI	cites ClinicalTrials.gov:NCT03141632; registry reference DERIVED:35134170